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Abstract: Metallic bone implants possess numerous problems limiting their long-term 
efﬁ cacy, such as poor prolonged osseointegration, stress shielding, and corrosion under in 
vivo environments. Such problems are compounded for bone cancer patients since numerous 
patients receive orthopedic implants after cancerous bone resection. Unfortunately, current 
orthopedic materials were not originally developed to simultaneously increase healthy bone 
growth (as in traditional orthopedic implant applications) while inhibiting cancerous bone growth. 
The long-term objective of the present research is to investigate the use of nano-rough selenium 
to prevent bone cancer from re-occurring while promoting healthy bone growth for this select 
group of cancer patients. Selenium is a well known anti-cancer chemical. However, what is not 
known is how healthy bone cells interact with selenium. To determine this, selenium, spherical 
or semispherical shots, were pressed into cylindrical compacts and these compacts were then 
etched using 1N NaOH to obtain various surface structures ranging from the micron, submicron to 
nano scales. Changes in surface chemistry were also analyzed. Through these etching techniques, 
results of this study showed that biologically inspired surface roughness values were created 
on selenium compacts to match that of natural bone roughness. Moreover, results showed that 
healthy bone cell adhesion increased with greater nanometer selenium roughness (more closely 
matching that of titanium). In this manner, this study suggests that nano-rough selenium should 
be further tested for orthopedic applications involving bone cancer treatment.
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Introduction
The most commonly used materials for bone implants are metals (such as titanium, Ti) 
and polymers (such as ultra high molecular weight polyethylene). Numerous prob-
lems exist with these implants such as (i) insufﬁ cient prolonged bonding between the 
implanted material and juxtaposed bone (Kaplan et al 1994a, 1994b; Buser et al 1999; 
Webster 2001), (ii) different mechanical properties between bone and the implant 
leading to stress shielding (Kaplan et al 1994a, 1994b; Webster 2001), and (iii) wear 
debris generated at articulating surfaces of orthopedic implants that may lead to cell 
death (Kaplan et al 1994a, 1994b). It has been speculated that nano-structured materials 
can increase orthopedic implant efﬁ cacy since it is well known that the nanometer 
scale is the length scale that most of the body’s natural materials possess. For example, 
hydroxyapatite, the major inorganic component of bone, exists predominantly as 
platelet-or rod-shape crystals about 2–5 nm in width and 50 nm in length. Type I col-
lagen, the major organic component of bone, has ﬁ brils 300 nm in length, 0.5 nm in 
width, and has a periodicity of 67 nm (Park and Lakes 1992). Therefore, it is reason-
able to consider that osteoblasts (or bone-forming cells) will be more accustomed to 
nano-structured surfaces compared to currently used nano-smooth implant surfaces.
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Such problems with promoting new bone growth 
next to implant surfaces are made only more complex for 
patients with bone cancer (both primary bone cancer and 
metastasized bone cancers). For example, it is estimated 
that 2,380 people will be diagnosed with bone and joint 
cancers and 1,470 people will die from primary bone and 
joint cancers in 2008 in the US (American Cancer Society 
2008). Primary bone cancer is rare but bone cancer as a 
result of the metastasis from other organs (such as the 
lungs, breasts and the prostate) is very common (Miller and 
Webster 2007). Thus, the number of patients afﬁ liated with 
bone cancer is much higher when considering the statistics 
of cancer metastasis. For these reasons, the main goal of this 
study was to introduce a new biomaterial naturally found 
in the human body that has chemopreventive properties for 
orthopedic implants: elemental selenium. The ﬁ rst goal in 
this effort was to create nano-structured roughness on such 
materials and to determine bone cell responses on such 
nano-structured selenium materials.
Materials and methods
Selenium shots (amorphous, metals basis, spherical and/or 
semi-spherical 2–4 mm in diameter; Alfa Asear, Ward Hill, 
MA) were pressed into cylindrical compacts (0.635 cm radius 
and 0.2 cm thickness) at 1000 psi for 2 minutes using a uni-
axial compacting hydraulic press (Carver, Inc., Wabash, IN). 
The compacts were then chemically treated with 1N NaOH 
for either 10 or 30 min. After etching, selenium compacts 
were washed with excessive deionized water to remove the 
NaOH that remained on the selenium compacts. Titanium 
substrates (Alfa Aesar) were used as controls.
Surfaces of untreated selenium compacts as well as sele-
nium compacts treated with 1N NaOH for 10 and 30 min were 
visualized (without a conductive coating) using a scanning 
electron microscope (SEM, LEO 1530VP FE-4800) with 
an accelerating voltage from 3 to 10 kV. Energy dispersive 
X-ray spectroscopy (EDS, LEO 1530) was used to determine 
the surface chemistry of the compacts.
To investigate osteoblast adhesion on selenium compacts, 
human osteoblast-like cells (bone-forming cells; CRL-11372 
American Type of Culture Collection, population numbers 
14–15) in Dulbecco’s Modiﬁ ed Eagle Media supplemented 
with 10% fetal bovine serum (Hyclone) and 1% Penicillin/
Streptomycin (Hyclone) were seeded at a density of 3500 
cells/cm2 and placed in an incubator under standard cell cul-
ture conditions (37 °C, 5% CO
2
, 95% humidiﬁ ed air) for 24 h. 
Importantly, this is an immortalized cell line which has been 
used widely in experiments involving orthopedic applications 
since previous studies have demonstrated that when cultured 
under similar conditions as described in the present study, 
these cells secrete bone-related proteins and deposit calcium 
containing mineral (Miller and Webster 2007). The cells were 
then ﬁ xed using 4% formaldehyde (Sigma, St. Louis, MO), 
stained with 4’,6-diamidino-2-phenylindole (DAPI) (Sigma) 
and counted under ﬂ uorescence microscopy (Zeiss Axiovert 
200M Light Microscope) in ﬁ ve random ﬁ elds which were 
averaged for each compact. Cell experiments were conducted 
in triplicate and repeated three times. Data were collected 
and statistical comparisons were assessed using a one-tailed 
Student t-test.
Results and discussion
The SEM images of the selenium compacts (untreated and 
treated with NaOH for different time periods) revealed 
various surface roughness. Untreated surfaces (Figure 1 
image A) possessed mostly micron rough surface features 
while those treated with 1N NaOH for different time periods 
created submicron (Figure 1 image B) and nano-rough 
(Figure 1 image C) surface features on selenium. In 
particular, biologically inspired surface roughness increased 
with increasing NaOH treatment time periods. As the etchant, 
NaOH is believed to dissolve the oxide layer on the surface 
Figure 1 SEM images of an untreated selenium compact (A) and selenium compacts treated with 1N NaOH for 10 min (B) and 30 min (C).
Note: Bars = 1 micrometer.
International Journal of Nanomedicine 2008:3(3) 393
Enhanced osteoblast adhension on nanostructured selenium compacts
of the selenium compacts creating submicron and nanometer 
features at increasing times.
Chemical etching is a very common, inexpensive, 
and simple method used to modify the surface properties 
(eg, topography, chemistry, roughness, wettability, etc.) 
of biomaterials. Chemical etching can be used for a wide 
range of biomaterials from metals, ceramics, to polymers. 
For example, etching titanium with HCl followed by NaOH 
has led to the formation of uniform micrometer featured 
surfaces that increased the formation of hydroxycarbonated 
apatite when exposed to a simulated body ﬂ uid (Jonasova 
et al 2004). Moreover, etching poly (lactic-co-glycolic 
acid) (PLGA) ﬁ lms using NaOH has created biologically 
inspired nanometer surface feature dimensions to promote 
the functions of numerous cells. For example, this nanometer 
PLGA structured surface was shown to promote bladder 
smooth muscle cell functions compared to conventional, 
micrometer-structured PLGA after 1, 3, and 5 days of culture 
(Thapa et al 2003). In addition, Feldspathic porcelain etched 
in 5% hydroﬂ uoric acid was shown to promote the bonding 
strength between orthodontic brackets and ceramic crowns 
when compared to those treated by mechanical roughening 
with ﬁ ne diamond burs or sandblasting (Schmage et al 2003). 
Clearly, chemical etching can be an inexpensive effective 
way to transform nano-smooth surfaces into nano-rough 
surfaces for a wide range of materials to promote their 
biological performance.
Importantly, EDS proﬁ les of the compacts used in 
the present study revealed that the chemistry of the sele-
nium compacts remained unaffected after treatment in 
1N NaOH (Figure 2). Moreover, Table 1 lists the weight 
percentages of selenium and sodium for each compact. 
The results showed trace amounts of sodium on the sur-
faces of selenium compacts treated with 1N NaOH. This 
indicated that chemical etching (ie, using 1N NaOH for 
up to 30 min) only changed the surface roughness, not the 
surface chemistry of the selenium compacts. The ability to 
change an implant’s surface roughness and/or topography 
without altering its chemistry is of great interest since, when 
fabricating implant materials, it is crucial not to induce any 
potential harmful chemistry changes. In this study, selenium 
compact chemistry remained unaltered after treatment 
with 1N NaOH for up to 30 min.
When these substrates were used as substrates for 
culturing osteoblasts, after 1 day, signiﬁ cantly increased 
cell densities were observed on the increasing nano-
rough surfaces (ie, compacts treated with 1N NaOH for 
10 and 30 min) (Figures 3, 4). Especially, the compacts 
treated with 1N NaOH for 30 min, which had the largest 
amount of nanometer surface features, had the highest 
osteoblast density. However, although closer, these 
selenium compacts (ie, compacts treated with 1N NaOH 
for 30 min) had osteoblast densities lower than that of 
titanium. Future studies will need to utilize greater times 
and/or concentrations of NaOH etching to determine if 
osteoblast adhesion can be matched between selenium and 
titanium. Moreover, future studies will need to examine 
primary osteoblast cells (since that was not accomplished 
here) as well as the multitude of cancerous cells that can 
cause bone cancer.
It has been shown that increased nanometer surface 
roughness promotes osteoblast functions (from adhesion to 
the deposition of calcium containing mineral) (Webster et al 
1999, 2000a, 2000b; Webster 2001; Webster and Ejiofor 
2004). The results of this study showed a similar trend of 
increased healthy osteoblast densities after 1 day of culture 
on selenium with increased nanometer surface roughness.
The signiﬁ cance of these results is also the introduction 
of a new chemistry to the orthopedic community 
particularly geared at inhibiting bone cancer regrowth: 
selenium. Selenium has been shown to have chemo-
preventive effects in numerous reports (Combs and 
Combs 1986; Clark et al 1991, 1998; Combs and Gray 
1998; Navarro-Alarcon and Lopez-Martinez 2000; Zhuo 
et al 2004; Wei et al 2004). However, the mechanisms 
of selenium-based chemoprevention are complex and 
incompletely understood (Combs 2001). By imparting 
nano features onto selenium compacts, the objective of 
this study was to create a material that promotes healthy 
osteoblast functions since evidence has already been pro-
vided concerning its role in inhibiting cancer growth. In 
the present study, healthy osteoblast adhesion was shown 
to be enhanced on nano-rough selenium compacts when 
compared to micro-rough selenium compacts. The reasons 
why nano-roughness enhances osteoblast functions remains 
incompletely understood. However, it has been shown that 
nano-roughness effectively increased the initial absorption 
of proteins (such as ﬁ bronectin and vitronectin) which 
mediate subsequent cell adhesion (Webster et al 2000b, 
2001; Khang et al 2007). In particular, particle boundaries 
on other material (Ti, Ti6Al4V, and CoCrMo) surfaces 
were shown to be active regions for such protein adsorp-
tion (Webster and Ejiofor 2004). Nano-structured surfaces 
clearly offer more particle boundaries when compared to 
micron-structured surfaces for promoting initial protein 
adsorption events.
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Figure 2 EDS profi les of (A) untreated selenium compacts and (B) selenium compacts treated with 1N NaOH for 10 min and (C) 30 min.
Table 1 Weight percentages of selenium (Se) and Na on Se compact 
surfaces*
Se compacts Weight % of Se Weight % of Na
Untreated 99.94 0.06
Treated with 1N NaOH 
for 10 min
99.82 0.18
Treated with 1N NaOH 
for 30 min
99.72 0.28
Note: *Data not statistically different.
In another recent study, elemental selenium nanoclusters 
were coated on conventional titanium substrates to create 
nano-structured surfaces. These surfaces were shown to 
promote healthy osteoblast functions after 1 day of culture 
and, importantly, inhibit cancerous osteoblast cell functions 
after 3 days of culture (Sarin et al 2008). In the present study, 
nano-structured selenium surfaces were created by a different 
method: chemically etching selenium bulk compacts. The 
approach used in this study is simpler than the coating method 
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Figure 3 Fluorescence microscopy images of osteoblasts on: (A) Untreated selenium compacts; (B) selenium compacts treated with 1N NaOH for 10 min; (C) selenium 
compacts treated with 1N NaOH for 30 min; and Titanium (Ti) substrates.
Note: Time = 24 h.
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Figure 4 Increased osteoblast densities on selenium compacts with greater amounts of nanosurface features after 24 h of culturing. (A) Untreated selenium compacts; 
(B) selenium compacts treated with 1N NaOH for 10 min; and (C) selenium compacts treated with 1N NaOH for 30 min.
Notes: Data = Mean ± SEM; N = 3; *p  0.05 compared to untreated substrate; **p  0.05 compared to compacts treated with 1N NaOH for 10 min. ***p  0.01 compared 
to compacts treated with 1N NaOH for 30 min.
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used (which involved selenium chemical precipitation) and 
can eliminate the inﬂ uence of titanium in the interaction with 
osteoblasts since selenium coatings in that previous study 
did not completely cover the underlying titanium. However, 
considering the toxicity of selenium at high levels (Whanger 
et al 1996), the use of selenium compacts may be problematic 
concerning how much selenium is exposed to the body lead-
ing to possible toxic effects. Future studies need to clearly 
investigate this possible toxicity as well as cancerous bone 
cell functions on these selenium compacts.
Conclusions
This study provided techniques to create nano-structured 
roughness without altering chemistry on selenium compacts 
for anti-cancer orthopedic applications. Since previous studies 
have shown greater osteoblast functions on nano-structured 
compared to conventional ceramics, metals, polymers, and 
composites, the ability to create nano-structured roughness 
on selenium compacts is promising for increasing bone cell 
functions, while inhibiting the return of bone cancer.
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